Current Board Members

Andrea Grubb Barthwell, MD, FASAM

Founding Chairwoman of the Board

Andrea Grubb Barthwell, M.D., D.F.A.S.A.M., is a Director at the comprehensive wellness center for the treatment of alcoholism and substance use disorders, Two Dreams Outer Banks and is the Chief Medical Officer of The Manor, Madison, Wisconsin. She is the founder and Chief Executive Officer of the Washington, DC-based global health care and policy-consulting firm EMGlobal LLC.

Genie Bailey, MD, DABAM

Genie Bailey, is currently an Associate Clinical Professor of Psychiatry and Human Behavior at the Warren Alpert Medical School of Brown University and is a Board Certified psychiatrist with 30 plus years of clinical and supervisory experience. She is also Diplomate of the American Board of Addiction Medicine and a Fellow in American Society of Addiction Medicine. Over the last decade, she has focused on substance abuse treatment and research at an internationally known treatment center, Stanley Street Treatment and Resources, Inc. (SSTAR) which is located in Fall River, Massachusetts.

Sonnie Kim

Sonnie Kim serves as Vice President of Medical & Scientific Affairs at Braeburn Pharmaceuticals. She has nearly 20 years of leadership experience driving medical affairs and scientific programs across a range of therapeutic areas, including pain management, addiction medicine and cardiovascular disease. At Braeburn, Dr. Kim oversees clinical trial design and execution for products in development and leads all medical affairs activities. Prior to joining Braeburn Pharmaceuticals, Dr. Kim was with Otsuka America Pharmaceutical, Inc., as a Director of Medical Affairs/Hospital Medicine and integral in the pre- and post-launch medical affairs activities and programs for SAMSCA, including development of phase 4 program, building health economic models and forming Medical Science Liaison team. Dr. Kim has previously been with WebMD, LLC, where she developed and deployed analytical tools to shape the strategy of WebMD’s Medscape Education program. Dr. Kim’s previous experience also includes roles as Vice President and Board member of Columbia Medcom Group, Inc., and it’s subsidiary, Medicallaince, Inc., and a teaching and clinical role at the University of Maryland School of Pharmacy. Dr. Kim holds a Doctorate of Pharmacy from the University of Maryland School of Pharmacy.

Behshad Sheldon

Chairwoman of the Board

Behshad Sheldon is the founder and Chairwoman of the Board of Directors for FORCE. She is the former President and CEO of Braeburn and through this role came to be a passionate defender of the rights of people with Opioid Use Disorder.

Shruti Kulkarni, J.D.

Secretary

Shruti Kulkarni is the Policy Director for the Center for Lawful Access and Abuse Deterrence (CLAAD), a not-for-profit organization working to reduce prescription drug abuse. In this role, she develops policy strategies to improve health care for individuals whose health or treatment has been affected by the nation’s prescription drug abuse and heroin epidemic. She is also a health care policy advisor at DCBA Law & Policy, a Washington, DC-based law firm.

Sharon L. Walsh, Ph.D.

Sharon Walsh, Ph.D. Is a Professor of Behavioral Science, Psychiatry, Pharmacology and Pharmaceutical Sciences and Director of the Center on Drug and Alcohol Research at the University of Kentucky. She has been conducting clinical research in substance abuse for nearly 25 years- much of it focused on understanding the behavioral pharmacology of opioid dependence and developing/improving pharmacotherapies for treatment of opioid dependence, including methadone and buprenorphine. She has published 100+ papers and book chapters, lectures widely on the topic and serves as a consultant to the FDA and other federal and state agencies.